ZNF350 and renal carcinoma: It revealed that 5 of 5 renal cancer cell lines and 4 of 5 renal cancer specimens manifest as noticeably down-regulation of ZBRK1 mRNA as compared with the corresponding controls (Figure 2A), suggesting that reduction of ZBRK1 expression may be involved in renal cancer development and progression.